• EOFLOW awarded a government grant to develop automatic insulin delivery system

  • EOFLOW is awarded a government R&D grant for developing a wearable disposable automatic insulin delivery system that functionally integrates a continuous glucose sensor and a wearable insulin pump to provide highly automated blood glucose control service with little or no user attention.  "This award, together with the recent award from JDRF (Juvenile Diabetes Research Foundation) and the licensing of the highly proven closed-loop algorithm from Typezero, will bring us one step closer to a successful launch of a wearable artificial pancreas solution," says Jesse Kim, the founding CEO of EOFLOW.

We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here